Effectiveness of Pharmacist-Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

• Glavni autori: Yukari Satsuma (Autor), Hiroaki Ikesue (Autor), Kaori Kusuda (Autor), Mami Maeda (Autor), Nobuyuki Muroi (Autor), Ryobu Mori (Autor), Mariko Kogo (Autor), Ryosuke Hirabayashi (Autor), Kazuma Nagata (Autor), Atsushi Nakagawa (Autor), Ryo Tachikawa (Autor), Keisuke Tomii (Autor), Tohru Hashida (Autor)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background: Pirfenidone is an anti-fibrotic agent used to treat patients with idiopathic pulmonary fibrosis (IPF). Managing adverse drug events and ensuring compliance with pirfenidone treatment for a prolonged period are important to reduce the rate of disease progression. To maximize the benefits...